Fortis Healthcare Ltd
Fortis Healthcare Ltd (FORTIS) last traded at ₹920, a market capitalisation of ₹69,456 crore, on a P/E of 65.0. Over the past 52 weeks the stock has ranged between ₹767 and ₹1,105. Fortis Healthcare Ltd last reported results for the quarter ended Jun 2026, with sales of ₹2,545 crore and net profit of ₹273 crore. Figures are as of 25 Aug 2026 and are not real time.
Fortis Healthcare Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Fortis Healthcare Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹2,545 cr, up 17.4% from ₹2,167 cr a year earlier. Net profit was ₹273 cr, up 2.2% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,988 | 1,928 | 2,007 | 2,167 | 2,331 | 2,265 | 2,365 | 2,545 |
| Expenses | 1,554 | 1,553 | 1,572 | 1,676 | 1,775 | 1,759 | 1,832 | 2,008 |
| Operating profit | 435 | 375 | 435 | 491 | 556 | 506 | 532 | 537 |
| OPM % | 22% | 19% | 22% | 23% | 24% | 22% | 23% | 21% |
| Other income | -42 | 47 | -29 | 31 | 50 | -34 | -2 | 28 |
| Interest | 36 | 45 | 68 | 70 | 75 | 86 | 84 | 80 |
| Depreciation | 95 | 97 | 102 | 101 | 106 | 120 | 122 | 122 |
| Profit before tax | 261 | 279 | 237 | 351 | 425 | 266 | 324 | 363 |
| Tax % | 26% | 9% | 21% | 24% | 23% | 26% | 16% | 25% |
| Net profit | 193 | 254 | 188 | 267 | 329 | 197 | 271 | 273 |
| EPS (₹) | 2.34 | 3.28 | 2.44 | 3.45 | 4.26 | 2.57 | 3.52 | 3.53 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Fortis Healthcare Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 4,030 | 5,718 | 6,298 | 6,893 | 7,783 | 9,128 | 9,506 |
| Operating profit | 404 | 1,069 | 1,101 | 1,268 | 1,588 | 2,085 | 2,131 |
| OPM % | 10% | 19% | 17% | 18% | 20% | 23% | 22% |
| Net profit | -56 | 790 | 633 | 645 | 809 | 1,064 | 1,070 |
| EPS (₹) | -1.45 | 7.35 | 7.80 | 7.93 | 10.26 | 13.80 | 13.88 |
TTM is the trailing twelve months to the most recent quarter.
Fortis Healthcare Ltd growth and returns
- 10 Years
- 8%
- 5 Years
- 18%
- 3 Years
- 13%
- TTM
- 18%
- 10 Years
- 60%
- 5 Years
- 64%
- 3 Years
- 27%
- TTM
- 16%
- 10 Years
- 18%
- 5 Years
- 27%
- 3 Years
- 40%
- 1 Year
- 0%
- 10 Years
- 5%
- 5 Years
- 9%
- 3 Years
- 10%
- Last Year
- 11%
Fortis Healthcare Ltd shareholding pattern
Promoters held 31.17% at Jun 2026, broadly unchanged since Jun 2025. FIIs 25.20% and DIIs 32.23%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% | 31.17% |
| FIIs | 25.26% | 26.77% | 27.40% | 27.18% | 27.90% | 27.84% | 25.98% | 25.20% |
| DIIs | 30.73% | 30.05% | 29.46% | 29.79% | 29.14% | 29.33% | 31.35% | 32.23% |
| Public | 12.83% | 12.02% | 11.98% | 11.87% | 11.79% | 11.65% | 11.50% | 11.40% |
| No. of shareholders | 2,04,184 | 2,21,750 | 2,18,329 | 2,05,373 | 2,20,766 | 2,33,156 | 2,26,685 | 2,20,743 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Fortis Healthcare Ltd corporate filings
- The relevant disclosure is attached.Company Updatelow impact
Cruxal's analysis: Fortis Healthcare has submitted a disclosure regarding its ESG rating. The filing is a…
Read the full analysis - Relevant disclosure attachedCompany Updatehigh impact
Cruxal's analysis: Fortis Healthcare reported consolidated revenue of INR 2,545 crore for Q1 FY27, a 17.5%…
Read the full analysis - Relevant disclosure attachedAGM/EGMlow impact
Cruxal's analysis: Fortis Healthcare Limited has successfully concluded its 30th Annual General Meeting held…
Read the full analysis - Proceeding of 30th Annual General MeetingAGM/EGMlow impact
Cruxal's analysis: Fortis Healthcare Limited has successfully concluded its 30th Annual General Meeting held…
Read the full analysis - Relevant disclosure is attachedCompany Updatelow impact
Cruxal's analysis: Fortis Healthcare Ltd has fulfilled its regulatory obligation under Regulation 30 of the…
Read the full analysis - Relevant disclosure is attachedCompany Updatelow impact
Cruxal's analysis: Fortis Healthcare Ltd has filed the outcome of its analyst/investor meeting held on…
Read the full analysis - The relevant disclosure is attached.Company Updatehigh impact
Cruxal's analysis: Fortis Healthcare Limited reported a robust Q1 FY27 performance with consolidated revenue…
Read the full analysis - The relevant disclosure is attached.Company Updatelow impact
Cruxal's analysis: Fortis Healthcare Ltd has filed a routine disclosure under Regulation 30 of the SEBI…
Read the full analysis - The relevant disclosure is attachedBoard Meetingmedium impact
Cruxal's analysis: Fortis Healthcare Limited reported consolidated revenue from operations of 2,545.03 crore…
Read the full analysis - The relevant disclosure is attached.Company Updatelow impact
Cruxal's analysis: Fortis Healthcare has submitted a routine intimation under Regulation 30 of the SEBI…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Fortis Healthcare Ltd
Cruxal reads every Fortis Healthcare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.